A systematic review of community opioid overdose prevention and naloxone distribution programs

Journal of Addiction Medicine

Volumn 8, Issue 3, 2014, Pages 153-163

  Clark, Angela K ^a   Wilder, Christine M ^b   Winstanley, Erin L ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Naloxone; Opioid overdose; Overdose prevention; Substance abuse services

Indexed keywords

NALOXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

COMPLICATION; DRUG OVERDOSE; HUMAN; MENTAL HEALTH SERVICE; MORTALITY; OPIATE ADDICTION; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROGRAM EVALUATION; SUPPLY AND DISTRIBUTION;

COMMUNITY MENTAL HEALTH SERVICES; DRUG OVERDOSE; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS; PROGRAM EVALUATION;

EID: 84904821872     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000034     Document Type: Review

References (51)

1. Beletsky L, Rich JD, Walley AY. Prevention of fatal opioid overdose. JAMA 2012;308:1863-1864.
2. Bennett AS, Bell A, Tomedi L, et al. Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. J Urban Health 2011;88:1020-1030.
3. Bennett T, Holloway K. The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN Project in Wales. Drugs Educ Prev Policy 2012;19:320-328.
4. Bowman S, McKenzie M, Rich J. Overdose prevention: naloxone with long acting opioids. Med Health R I 2008;91:271-272.
5. Boyer EW. Management of opioid analgesic overdose. N Engl J Med 2012;367:146-155.
6. Branagan O, Grogan L. Providing health education on accidental drug overdose. Nurs Times 2006;102:32-33.
7. Buajordet I, Naess A, Jacobsen D, et al. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med 2004;11:19-23.
8. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. Morb Mortal Wkly Rep 2011;60:1487-1492.
9. Centers for Disease Control and Prevention. National Center for Injury Prevention and Control: data and statistics Web-based injury statistics query and reporting system 2005. 2013. Available at: http://www.cdc.gov/injury/ wisqars/LeadingCauses.html. Accessed September 13, 2013.
10. Clarke S, Dargan P, Jones A. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J 2005;22:612-616.
11. Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology 2010;112:226-238.
12. Darke S, Hall W. The distribution of naloxone to heroin users. Addiction 1997;92:1195-1199.
13. Darke S, Williamson A, Ross J, et al. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. J Urban Health 2007;84:283-291.
14. Davis C, Webb D, Burris S. Changing law from barrier to facilitator of opioid overdose prevention. J Law Med Ethics 2013;41(suppl 1):33-36.
15. Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ 2001;322:895-896.
16. Doe-Simkins M, Walley AY, Epstein A, et al. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 2009;99:788-791.
17. Enteen L, Bauer J, McLean R, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010;87:931-941.
18. Galea S, Worthington N, Markham Piper T, et al. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav 2006;31:907-912.
19. Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction 2008;103: 979-989.
20. Heller DI, Stancliff S. Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City. Public Health Rep 2007;122:393-397.
21. Jinks A, Cotton A, Rylance R. Obesity interventions for people with a learning disability: an integrative literature review. J Adv Nurs 2011;67:460-471.
22. Jones JD, Roux P, Stancliff S, et al. Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users. Int J Drug Policy 2014;25:166-170.
23. Lankenau SE, Wagner KD, Silva K, et al. Injection drug users trained by overdose prevention programs: responses to witnessed overdoses. J Community Health 2013;38:133-141.
24. Leece P, Orkin A. Opioid overdose fatality prevention. JAMA 2013;309:873-874.
25. Leece PN, Hopkins S, Marshall C, et al. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario. Can J Public Health 2013;104:e200-e204.
26. Lenton SR, Dietze PM, Degenhardt L, et al. Naloxone for administration by peers in cases of heroin overdose. Med J Aust 2009a;191:469.
27. Lenton SR, Dietze PM, Degenhardt L, et al. Now is the time to take steps to allow peer access to naloxone for heroin overdose in Australia. Drug Alcohol Rev 2009b;28:583-585.
28. Lopez Gaston R, Best D, Manning V, et al. Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? Harm Reduct J 2009;6:26.
29. Markham Piper T, Stancliff S, Rudenstine S, et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse 2008;43:858-870.
30. Maxwell S, Bigg D, Stanczykiewicz K, et al. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006;25:89-96.
31. Mayet S, Manning V, Williams A, et al. Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: effective, but dissemination is challenging. Int J Drug Policy 2011;22:9-15.
32. McAuley A, Lindsey G, Woods M, et al. Responsible management and use of a personal take-home naloxone supply: a pilot project. Drugs Educ Prev Policy 2010;17:388-399.
33. Neira-León M, Barrio G, Bravo MJ, et al. Infrequent opioid overdose risk reduction behaviours among young adult heroin users in cities with wide coverage of HIV prevention programmes. Int J Drug Policy 2011;22:16-25.
34. Oldham NS, Wright NMJ. A UK policy on 'take home naloxone' for opiate users-strategy or stalemate? Drugs Educ Prev Policy 2003;10:105-119.
35. Paulozzi LJ. Prescription drug overdoses: a review. J Saf Res 2012;43:283-289.
36. Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health 2001;91:1842-1846.
37. Sherman SG, Gann DS, Scott G, et al. A qualitative study of overdose responses among Chicago IDUs. Harm Reduct J 2008;5:2.
38. Sporer KA, Kral AH. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007;49:172-177.
39. Strang J, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008a;103:1648-1657.
40. Strang J, Manning V, Mayet S, et al. Family carers and the prevention of heroin overdose deaths: unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone. Drugs Educ Prev Policy 2008b;15:211-218.
41. Substance Abuse and Mental Health Services Administration. Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011. NSDUH Series H-41, HHS publication no. (SMA) 11-4658.
42. Thurmond P, Bowman S. An overview of heroin overdose prevention in the northeast: new opportunities. Med Health R I 2007;90:148-151.
43. Tobin K, Davey M, Latkin C. Calling emergency medical services during drug overdose: an examination of individual, social and setting correlates. Addiction 2005;100:397-404.
44. Tobin KE, Sherman SG, Beilenson P, et al. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 2009;20:131-136.
45. Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy 2010;21:186-193.
46. Walley AY, Doe-Simkins M, Quinn E, et al. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat 2013a;44:241-247.
47. Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013b;346:f174.
48. Wheeler E, Davidson PJ, Jones TS, et al. Community-based opioid overdose prevention programs providing naloxone-United States, 2010.Morb Mortal Wkly Rep 2012;61:101-105.
49. Worthington N, Markham Piper T, Galea S, et al. Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study. Harm Reduct J 2006;3:19.
50. Wright N, Oldham N, Francis K, et al. Homeless drug users' awareness and risk perception of peer "Take Home Naloxone" use-a qualitative study. Subst Abuse Treat Prev Policy 2006;1:28.
51. Yokell MA, Green TC, Bowman S, et al. Opioid overdose prevention and naloxone distribution in Rhode Island. Med Health Rhode Island 2011;94:240-242.